All the events here are relevant to people working in dementia research. If you would like to add your own you can submit an event
- This event has passed.
UCL Motor Neuron Disease Hybrid International Symposium
08/09/2023 @ 10:00 am - 6:00 pm
The Fourth UCL Queen Square Motor Neuron Disease Centre Hybrid International Symposium: Friday 8th September 2023
The programme includes:
SESSION 1: KEYNOTE AND NOVEL TRIAL PLATFORMS IN MND/ALS
- KEYNOTE SPEAKER: Leonard van den Berg, University Medical Center Utrecht, Netherlands – ‘Translation in motor neuron diseases / TRICALS platform’
- Caroline Ingre, Clinical Neuroscience, Karolinska University Hospital, Sweden – ‘Tricals programme / update on clinical trials’
- Suvankar Pal, Centre for Clinical Brain Sciences, University of Edinburgh – ‘MND SMART trials using conventional drugs’
SESSION 2: MND/ALS CLINICAL TRIALS – WHAT DOES SUCCESS LOOK LIKE?
- Pamela Shaw, Sheffield Institute for Translational Neuroscience (SITraN) – ‘ASO: Tofersen trial- SOD1’
- Michael Benatar, Miller School of Medicine, University of Miami – ‘ATLAS trial – pre-symptomatic SOD1’
- Kevin Eggan, CSO/Senior Vice President, Head of Research & Early Development, Biomarin, USA – ‘Progress and challenges with Stathmin-related research/trials and KCNQ2’
- Jeffrey Rothstein, Robert Packard Centre for ALS Research, John Hopkins MDA ALS Clinic – ‘Update on clinical trials and the issues facing those trials from Hopkins/Packard experience’
- Nigel Leigh, Brighton and Sussex Medical School, University of Sussex – ‘MiroCALS (IL-2 treatment)’
- Leonard Petrucelli, Neurodegenerative Diseases Lab, Mayo Clinic, USA – ‘Title TBC’
SESSION 3: NEW THERAPEUTIC TARGETS AND CHALLENGES
- Anne Bertolotti, MRC Laboratory of Molecular Biology, Cambridge – ‘Translation in ALS’
- Anna Leigh Brown, UCL Queen Square Institute of Neurology – ‘UNC13A, a new target for ALS therapeutics’
- Elizabeth Fisher, UCL Queen Square Institute of Neurology – ‘Humanised mouse models and the need for more mouse models’
SESSION 4: NEW INITIATIVES IN MND/ALS
- Ammar Al Chalabi, King’s College London / Co-Lead, UK MND Research Institute – ‘An introduction to the UK MND Research Institute’
- Paul Wright, LifeArc – ‘LifeArc MND Translational Challenge’
CPD accreditation from the Federation of the Royal College of Physicians is pending
